KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Income towards Parent Company (2016 - 2025)

LifeMD (LFMD) has disclosed Income towards Parent Company for 14 consecutive years, with -$5.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 40.29% year-over-year to -$5.9 million, compared with a TTM value of -$13.3 million through Dec 2025, up 40.03%, and an annual FY2025 reading of $24.6 million, up 961.93% over the prior year.
  • Income towards Parent Company was -$5.9 million for Q4 2025 at LifeMD, down from -$2.2 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$2.2 million in Q1 2025 and bottomed at -$18.0 million in Q4 2021.
  • Average Income towards Parent Company over 5 years is -$7.9 million, with a median of -$6.3 million recorded in 2024.
  • The sharpest move saw Income towards Parent Company tumbled 393.98% in 2021, then skyrocketed 76.52% in 2023.
  • Year by year, Income towards Parent Company stood at -$18.0 million in 2021, then skyrocketed by 51.51% to -$8.7 million in 2022, then surged by 67.98% to -$2.8 million in 2023, then crashed by 50.75% to -$4.2 million in 2024, then crashed by 40.29% to -$5.9 million in 2025.
  • Business Quant data shows Income towards Parent Company for LFMD at -$5.9 million in Q4 2025, -$2.2 million in Q3 2025, and -$3.0 million in Q2 2025.